Matrix metalloproteinase inhibitors and cancer
Janelle L. Lauer‐Fields, Gregg B. Fields
Abstract
Janelle L. Lauer‐Fields, Gregg B. Fields
Abstract
The matrix metalloproteinase (MMP) family plays an integral role in both normal and pathological connective tissue remodeling. The accelerated local turnover of the extracellular matrix is often found in tumour cell invasion and metastasis. The development of MMP inhibitors thus offers a promising strategy to modulate metastasis. This review describes developments in MMP inhibitor research and patents related to cancer since 1998.
OpenAlex reports 9 citations for this work. Citation counts describe recorded attention and do not establish research quality.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
The matrix metalloproteinase (MMP) family plays an integral role in both normal and pathological connective tissue remodeling. The accelerated local turnover of the extracellular matrix is often found in tumour cell invasion and metastasis. The development of MMP inhibitors thus offers a promising strategy to modulate metastasis. This review describes developments in MMP inhibitor research and patents related to cancer since 1998.
Key concepts: Matrix metalloproteinase, Extracellular matrix, Metastasis, Cancer, Cancer research, Matrix metalloproteinase inhibitor, Cancer metastasis, Tissue inhibitor of metalloproteinase